Copperlife Pain Relief Liquid

Description

The drug is presented as a liquid spray formulation, designed for ease of application. It is contained within a 2.5 oz container, ensuring a convenient dosage for users. The product label features a reference to an image of the product, providing visual identification.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with simple backaches, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

Healthcare professionals should instruct patients to shake the product well before use. For adults and children aged 12 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. For children under 12 years of age, it is advised to consult a doctor prior to use.

Contraindications

There are no specific contraindications listed for this product. However, it is advised that if the product is swallowed, medical assistance should be sought immediately or contact a Poison Control Center.

Warnings and Precautions

This product is intended for external use only and is flammable; therefore, it must be kept away from fire or flame to prevent any risk of ignition.

Healthcare professionals should advise patients to avoid contact with the eyes while using this product. In the event of accidental eye contact, it is crucial to flush the eyes thoroughly with water. Additionally, the product should not be applied to wounds or damaged skin. Patients should be instructed not to bandage the area tightly and to refrain from using the product in conjunction with a heating pad. The contents of the product are under pressure; thus, it is imperative not to puncture or incinerate the container. Furthermore, the product should not be stored at temperatures exceeding 120°F to maintain its integrity and safety.

Patients should be closely monitored for any worsening of their condition. If symptoms persist for more than 7 days or if they resolve and then recur within a few days, it is essential to discontinue use and consult a healthcare professional for further evaluation.

In cases of ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay to ensure appropriate management.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. This product is intended for external use only and is flammable; therefore, it should be kept away from fire or flame. Users must avoid contact with the eyes; in the event of contact, the eyes should be flushed thoroughly with water. The product should not be applied to wounds or damaged skin, and it is advised not to bandage the area tightly. Additionally, it should not be used in conjunction with a heating pad.

The contents of this product are under pressure, and users should not puncture or incinerate the container. It is also crucial to store the product at temperatures not exceeding 120°F. Patients are advised to discontinue use and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Copperlife Pain Relief Liquid (menthol 16%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. Caution is advised when administering to younger children, and appropriate medical guidance is essential.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional regarding the use of this medication. It is important for healthcare providers to assess the potential risks and benefits before prescribing this medication to women of childbearing potential. The safety of this medication during pregnancy and lactation has not been fully established, and caution is advised.

Lactation

Lactating mothers are advised to consult a healthcare professional if they are pregnant or breastfeeding. There is no specific data available regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, healthcare providers should evaluate the potential risks and benefits before prescribing this medication to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, respiratory depression, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include airway management, monitoring of vital signs, and intravenous fluid administration as necessary. The use of specific antidotes or treatments should be guided by the clinical scenario and the substances involved.

For further management, consultation with a poison control center or a medical toxicologist is recommended to ensure appropriate therapeutic interventions are implemented. Continuous assessment and supportive care remain critical components in the management of overdose cases.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that in the event of accidental ingestion, it is crucial to seek medical assistance immediately or contact a Poison Control Center. This information is vital for ensuring patient safety and prompt intervention in case of an emergency.

Storage and Handling

The product is supplied in containers that are under pressure. It is imperative that these containers are not punctured or incinerated to ensure safety and integrity.

For optimal storage, the product must be kept at temperatures not exceeding 120°F. Proper adherence to these storage conditions is essential to maintain the quality and efficacy of the product.

Additional Clinical Information

The product is administered topically, with a recommended application frequency of 3 to 4 times daily for adults and children aged 12 years and older. For children under 12 years, consultation with a doctor is advised.

Clinicians should counsel patients that the product is for external use only and is flammable; it should be kept away from fire or flame. Patients should avoid contact with eyes, and in case of contact, they should flush thoroughly with water. The product should not be applied to wounds or damaged skin, nor should it be bandaged tightly or used with a heating pad. It is important to note that the contents are under pressure, and the product should not be punctured or incinerated. Storage should not exceed 120°F. Patients are advised to discontinue use and consult a doctor if the condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and recur within a few days. Pregnant or breastfeeding individuals should seek advice from a health professional. In the event of ingestion, medical assistance or contact with a Poison Control Center is necessary. Patients should shake the product well before use.

Drug Information (PDF)

This file contains official product information for Copperlife Pain Relief Liquid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)